These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 24565643

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors.
    Fazio F, Lionetto L, Molinaro G, Bertrand HO, Acher F, Ngomba RT, Notartomaso S, Curini M, Rosati O, Scarselli P, Di Marco R, Battaglia G, Bruno V, Simmaco M, Pin JP, Nicoletti F, Goudet C.
    Mol Pharmacol; 2012 May; 81(5):643-56. PubMed ID: 22311707
    [Abstract] [Full Text] [Related]

  • 3. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L, Abad C, Leclercq M, Miel C, Jean L, Riou G, Couvineau A, Boyer O, Tan YV.
    J Neuroinflammation; 2019 Mar 20; 16(1):64. PubMed ID: 30894198
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V, Tselios T, Kanistras I, Koutsoni O, Karamita M, Vamvakas SS, Apostolopoulos V, Dotsika E, Matsoukas J, Lassmann H, Probert L.
    Exp Neurol; 2015 May 20; 267():254-67. PubMed ID: 25447934
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Controlled delivery of a metabolic modulator promotes regulatory T cells and restrains autoimmunity.
    Gammon JM, Tostanoski LH, Adapa AR, Chiu YC, Jewell CM.
    J Control Release; 2015 Jul 28; 210():169-78. PubMed ID: 26002150
    [Abstract] [Full Text] [Related]

  • 8. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J, Wingerath B, Graf J, Lepka K, Hofrichter M, Schröter F, Wedekind F, Bauer A, Schrader J, Hartung HP, Prozorovski T, Aktas O.
    J Neuroinflammation; 2016 Feb 26; 13():48. PubMed ID: 26920550
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of orexin-A in experimental autoimmune encephalomyelitis.
    Fatemi I, Shamsizadeh A, Ayoobi F, Taghipour Z, Sanati MH, Roohbakhsh A, Motevalian M.
    J Neuroimmunol; 2016 Feb 15; 291():101-9. PubMed ID: 26857503
    [Abstract] [Full Text] [Related]

  • 12. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK, Kannarkat GT, Chung J, Joon Lee H, Graham KL, Tansey MG.
    J Neuroinflammation; 2016 Feb 01; 13():24. PubMed ID: 26831924
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunomodulation By Subchronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.
    Yang EJ, Stokes JV, Kummari E, Eells J, Kaplan BL.
    Toxicol Sci; 2016 May 01; 151(1):35-43. PubMed ID: 26822306
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.